Factors associated with pain in individuals infected by human T-cell lymphotropic virus type 1 (HTLV-1)

The Brazilian Journal of Infectious Diseases - Tập 21 - Trang 133-139 - 2017
Dislene N. dos Santos1,2,3, Kionna O.B. Santos2, Alaí B. Paixão2, Rosana Cristina P. de Andrade3, Davi T. Costa3,4, Daniel L. S-Martin2,5, Katia N. Sá2,6, Abrahão F. Baptista1,2,6
1Universidade Federal da Bahia, Programa de Pós-graduação em Medicina e Saúde, Salvador, BA, Brazil
2Universidade Federal da Bahia, Laboratório de Eletroestimulação Funcional, Salvador, BA, Brazil
3Universidade Federal da Bahia, Hospital Professor Edgard Santos, Serviço de Imunologia, Salvador, BA, Brazil
4Universidade Estadual do Sudoeste da Bahia, Vitoria da Conquista, BA, Brazil
5Universidade Federal da Bahia, Faculdade de Medicina da Bahia, Salvador, BA, Brazil
6Escola Bahiana de Medicina e Saúde Pública, Pós graduação e pesquisa, Salvador, BA, Brazil

Tài liệu tham khảo

Gessain, 2012, Epidemiological aspects and world distribution of HTLV-1 infection, Front Microbiol, 3, 1, 10.3389/fmicb.2012.00388 Hlela, 2009, The prevalence of human T-cell lymphotropic virus type 1 in the general population is unknown, AIDS Rev, 11, 205 Vrielink, 2004, HTLV-I/II prevalence in different geographic locations, Transfus Med Rev, 18, 46, 10.1016/j.tmrv.2003.10.004 Carneiro-Proietti, 2002, Infecção e doença pelos vírus linfotrópicos humanos de células T (HTLV-I/II) no Brasil, Rev Soc Bras Med Trop, 35, 499, 10.1590/S0037-86822002000500013 Catalan-Soares, 2005, Heterogeneous geographic distribution of human T-cell lymphotropic viruses I and II (HTLV-I/II): serological screening prevalence rates in blood donors from large urban areas in Brazil, Cad Saude Publ, 21, 926, 10.1590/S0102-311X2005000300027 Dourado, 2003, HTLV-I in the general population of Salvador, Brazil: a city with african ethnic and sociodemographic characteristics, J Acquir Immune Defic Syndr, 34, 527, 10.1097/00126334-200312150-00013 Araujo, 2006, The HTLV-1 neurological complex, Lancet Neurol, 5, 1068, 10.1016/S1474-4422(06)70628-7 Kamoi, 2012, HTLV-1 uveitis, Front Microbiol, 3, 1, 10.3389/fmicb.2012.00270 de Carvalho, 2006, Doenças reumáticas auto-imunes em indivíduos infectados pelo HTLV-1, Rev Bras Reumatol, 46, 334, 10.1590/S0482-50042006000500006 Poetker, 2011, Clinical manifestations in individuals with recent diagnosis of HTLV type I infection, J Clin Virol, 51, 54, 10.1016/j.jcv.2011.02.004 Caskey, 2007, Clinical manifestations associated with HTLV type I infection: a cross-sectional study, AIDS Res Hum Retroviruses, 23, 365, 10.1089/aid.2006.0140 Tanajura, 2013, Sensory symptoms and immune response in individuals infected with HTLV-1, Clin Exp Med Sci, 1, 1, 10.12988/cems.2013.13001 Saeidi, 2011, Prevalence of peripheral neuropathy in patients with HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP), Acta Neurol Belg, 111, 41 Mendes, 2013, Pain is highly prevalent in individuals with tropical spastic paraparesis, Health Care (Don Mills), 1, 47, 10.12966/hc.11.01.2013 Santos, 2004, Exacerbated inflammatory cellular immune response characteristics of HAM/TSP is observed in a large proportion of HTLV-I asymptomatic carriers, BMC Infect Dis, 4 Carvalho, 2001, Cytokine profile and immunomodulation in asymptomatic human T-lymphotropic virus type 1-infected blood donors, J Acquir Immune Defic Syndr, 27, 1, 10.1097/00126334-200105010-00001 De Castro-Costa, 2009, Pain in tropical spastic paraparesis/HTLV-I associated myelopathy patients, Arq Neuropsiquiatr, 67, 866, 10.1590/S0004-282X2009000500016 Franzoi, 2007, Disability and determinants of gait performance in tropical spastic paraparesis/HTLV-I associated myelopathy (HAM/TSP), Spinal Cord, 45, 64, 10.1038/sj.sc.3101919 Martins, 2012, Quality of life in patients with HTLV-I associated myelopathy/tropical spastic paraparesis, Arq Neuropsiquiatr, 70, 257, 10.1590/S0004-282X2012005000006 Gascón, 2011, Prevalence of anxiety, depression and quality of life in HTLV-1 infected patients, Braz J Infect Dis, 15, 578, 10.1590/S1413-86702011000600013 Netto, 2011, Characteristics of chronic pain and its impact on quality of life of patients with HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP), Clin J Pain, 27, 131, 10.1097/AJP.0b013e3181f195d3 De Castro-Costa, 2006, Proposal for diagnostic criteria of tropical spastic paraparesis/HTLV-I-associated myelopathy (TSP/HAM), AIDS Res Hum Retroviruses, 22, 931, 10.1089/aid.2006.22.931 Matsuzaki, 2000, HTLV-I-associated myelopathy (HAM)/tropical spastic paraparesis (TSP) with amyotrophic lateral sclerosis-like manifestations, J Neurovirol, 6, 544, 10.3109/13550280009091955 Kurtzke, 1983, Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS), Neurology, 33, 1444, 10.1212/WNL.33.11.1444 Merskey, 1994 Castro, 2006, Validade da escala hospitalar de ansiedade e depressão em pacientes com dor crônica, Rev Bras Anestesiol, 56, 470, 10.1590/S0034-70942006000500005 Coutinho, 2008, Métodos para estimar razão de prevalência em estudos de corte transversal, Rev Saude Publ, 42, 992, 10.1590/S0034-89102008000600003 Tavares, 2010, Low-back pain in HTLV-I-associated myelopathy/tropical spastic paraparesis: nociceptive or neuropathic?, Spinal Cord, 48, 134, 10.1038/sc.2009.83 Bangham, 2000, HTLV-1 infections, J Clin Pathol, 53, 581, 10.1136/jcp.53.8.581 Bangham, 2003, The immune control and cell-to-cell spread of human T-lymphotropic virus type 1, J Gen Virol, 84, 3177, 10.1099/vir.0.19334-0 Iwasaki, 1990, Pathology of chronic myelopathy associated with HTLV-I infection (HAM/TSP), J Neurol ci, 96, 103 Britto, 2014, Proprioceptive neuromuscular facilitation in HTLV-I-associated myelopathy/tropical spastic paraparesis, Rev Soc Bras Med Trop, 47, 24, 10.1590/0037-8682-0245-2013 Cartier, 2005, Presence of HTLV-I Tax protein in cerebrospinal fluid from HAM/TSP patients, Arch Virol, 150, 743, 10.1007/s00705-004-0443-3 Ribas, 2002, Mielopatia associada ao vírus linfotrópico humano de células T do tipo 1 (HTLV-1), Rev Soc Bras Med Trop, 35, 377, 10.1590/S0037-86822002000400015 Teng, 2005, Depressão e comorbidades clínicas, Rev Psiquiatr Clín, 32, 149, 10.1590/S0101-60832005000300007 Loyola Filho, 2002, Prevalência e fatores associados à automedicação: resultados do projeto Bambuí, Rev Saude Publ, 36, 55, 10.1590/S0034-89102002000100009 Arrais, 2005, Prevalência e fatores determinantes do consumo de medicamentos no Município de Fortaleza, Ceará, Brasil, Cad Saude Publ, 21, 1737, 10.1590/S0102-311X2005000600021 Silverstein, 2000, Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis, JAMA, 284, 1247, 10.1001/jama.284.10.1247 Wannmacher, 2004, Antiinflamatórios não-esteróides: Uso indiscriminado de inibidores seletivos de cicloxigenase-2, Fut Farmacêut, 1, 1 Moseley, 2003, A pain neuromatrix approach to patients with chronic pain, Man Ther, 8, 130, 10.1016/S1356-689X(03)00051-1 Neto, 2012, Fortalecimento muscular em pacientes com HTLV-1 e sua influência no desempenho funcional: um estudo piloto, Rev Pesqui em Fisioter, 2, 143 Borges, 2014, Pilates exercises improve low back pain and quality of life in patients with HTLV-1 virus: a randomized crossover clinical trial, J Bodyw Mov Ther, 18, 68, 10.1016/j.jbmt.2013.05.010 Nijs, 2012, Dysfunctional endogenous analgesia during exercise in patients with chronic pain: to exercise or not to exercise?, Pain Phys, 15, ES205, 10.36076/ppj.2012/15/ES205 Souza, 2009, De. Poderia a atividade física induzir analgesia em pacientes com dor crônica?, Rev Bras Med do Esporte, 15, 145, 10.1590/S1517-86922009000200013 Faria, 2006, Religiosidade, enfrentamento e bem-estar subjetivo em pessoas vivendo com HIV/AIDS, Psicol Estud, 11, 155, 10.1590/S1413-73722006000100018 Moreira-Almeida, 2006, Religiousness and mental health: a review, Rev Bras Psiquiatr, 28, 242, 10.1590/S1516-44462006005000006